XML 27 R15.htm IDEA: XBRL DOCUMENT v3.25.3
Stockholders' Equity
9 Months Ended
Sep. 28, 2025
Equity [Abstract]  
Stockholders' Equity Stockholders’ Equity
Dividends

During the first, second, and third quarters of 2025, the Company paid dividends per share of $.25, $.14 and $.14, respectively. During each of the first, second, and third quarters of 2024, the Company paid dividends per share of $.25.

Repurchases of Common Stock

In January 2023, our Board of Directors authorized a repurchase program for up to $500,000 of our common stock through February 28, 2027, when and if market conditions warrant and to the extent legally permissible (the “January 2023 Authorization”). During the nine months ended September 28, 2025, the Company repurchased 14,361 shares under the January 2023 Authorization with an aggregate purchase price of $200,000, excluding excise tax of $1,930 and commissions of $201. During the nine months ended September 28, 2025, the Company paid $565 in excise tax on shares repurchased during 2024. As of September 28, 2025, the Company had $35,000 of availability remaining under the January 2023 Authorization.

During the nine months ended September 29, 2024, the Company repurchased 3,447 shares under the January 2023 Authorization with an aggregate purchase price of $59,637, of which $203 was accrued as of September 29, 2024, and excluding excise tax of $441 and commissions of $49.
Accumulated Other Comprehensive Loss

The following table provides a rollforward of accumulated other comprehensive loss, which is entirely comprised of foreign currency translation:
Nine Months Ended
September 28,
2025
September 29,
2024
Balance at beginning of period$(74,753)$(58,375)
Foreign currency translation
7,313 (2,215)
Balance at end of period$(67,440)$(60,590)